Cargando…
Oral Polio Vaccine to Mitigate the Risk of Illness and Mortality During the Coronavirus Disease 2019 Pandemic: A Cluster-Randomized Trial in Guinea-Bissau
BACKGROUND: Oral polio vaccine (OPV) may improve resistance to non-polio-infections. We tested whether OPV reduced the risk of illness and mortality before coronavirus disease 2019 (COVID-19) vaccines were available. METHODS: During the early COVID-19 pandemic, houses in urban Guinea-Bissau were ran...
Autores principales: | Fisker, Ane B, Martins, Justiniano S D, Nanque, Line M, Jensen, Andreas M, Ca, Elsi J C, Nielsen, Sebastian, Martins, Cesario L, Rodrigues, Amabelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494416/ https://www.ncbi.nlm.nih.gov/pubmed/36193229 http://dx.doi.org/10.1093/ofid/ofac470 |
Ejemplares similares
-
Health effects of utilising hospital contacts to provide measles vaccination to children 9–59 months—a randomised controlled trial in Guinea-Bissau
por: Fisker, Ane B., et al.
Publicado: (2022) -
BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study
por: Thysen, Sanne Marie, et al.
Publicado: (2014) -
The effect of vitamin A supplementation administered with missing vaccines during national immunization days in Guinea-Bissau
por: Benn, Christine Stabell, et al.
Publicado: (2009) -
Stopping Oral Polio Vaccine (OPV) After Defeating Poliomyelitis in Low- and Middle-Income Countries: Harmful Unintended Consequences? Review of the Nonspecific Effects of OPV
por: Aaby, Peter, et al.
Publicado: (2022) -
Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study
por: Funch, Katarina M., et al.
Publicado: (2018)